Method for treating cancer
AssigneeEpizyme, Inc.
InventorHeike Keilhack
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for treating or alleviating a symptom of a disorder, e.g., immune evasion, cancer-cell induced immune dysfunction, reduced immune response, lowered inflammation, decreased expression of a major histocompatibility complex (MHC), or cancer, characterized by aberrant, misregulated, or increased Enhancer of Zeste Homolog 2 (EZH2) activity in a cell or subject in need thereof by contacting the cell or administering to the subject a therapeutically effective amount of an EZH2 inhibitor.
Claims19
1-22. (canceled)
A method for treating or alleviating a symptom of a cancer in a human subject comprising administering to the human subject Compound A:
- or a pharmaceutically effective salt thereof;
- wherein the human is characterized by reduced expression of one or more of major histocompatibility complex (MHC), β2 microglobulin, Tumor Necrosis Factor (TNF) receptor, Low Molecular Mass Polypeptide 2, (LMP2), Low Molecular Mass Polypeptide 7, (LMP7), Transporter Associated with Antigen Processing (TAP), and TAP-associated glycoprotein (tapasin) in a cancer cell when compared to a non-cancerous cell.
Dependencies are inferred from the claim text.